In India, there were 8.74 lakh deaths due to cancer in 2024. Russia’s MRNA cancer vaccine was researched for many years and pre-clinical trials were performed for 3 years.
Cancer vaccine pre-clinical trial
Russia’s cancer vaccine has passed a preclinical trial and is ready for use. Its safety and effectiveness was confirmed in a 3 -year trial. This information was provided by Veronica Squartsova, head of Russia’s Federal Medical and Biological Agency. Veronica said the vaccine was ready for use. We are waiting for official approval. The effect of the vaccine was very good even after frequent use.
Will not require chemotherapy?
Researchers saw a 60% to 80% decrease in tumor size after using the vaccine. The initial goal of the vaccine will be Colorectal Cancer. In addition, there has been good progress in developing vaccines for glioblastoma and various types of melanoma. The vaccine made by Russia is a MRNA vaccine. It will be stimulated according to each patient’s RNA. If the vaccine is approved, chemotherapy will not be needed. The British government is developing a cancer vaccine in collaboration with BioNetech in Germany. American pharmaceutical companies are also making vaccines to fight skin cancer.
Cancer is increasing case
In India, 4.60 lakh men died due to cancer in 2024. At the same time, 4.14 lakh women have lost their lives. That is, the death of cancer in men was more than women. According to ICMR, the Indian Council for Medical Research, cancer patients in India will increase by 12%in the next 5 years. In this, even younger people will quickly suffer cancer. According to a research published in the Nature Journal, our lifestyle is the biggest reason for cancer at a young age.
Disclaimer: Some information in the news is based on media reports. Message News does not confirm the matter. You should consult a relevant specialist before implementing any suggestion.
